The use of different types of chemicals in upstream oilfield operations is critical for optimizing the different operations involved in hydrocarbon exploration and production. Surfactants are a type chemical that are applied in various upstream operations, such as drilling, fracturing, and enhanced oil recovery. However, due to their nonbiodegradability and toxicity, the use of synthetic surfactants has raised environmental concerns. Natural surfactants have emerged because of the hunt for sustainable and environmentally suitable substitutes. This Review discusses the role of natural surfactants in upstream operations as well as their benefits and drawbacks. The Review discusses the basic characteristics of surfactants, their classification, and the variables that affect their performance. Finally, the Review examines the possible applications of natural surfactants in the upstream oil sector and identifies areas that require further research.
Age-related macular degeneration (AMD) poses a significant threat to visual health among the elderly, necessitating urgent preventive measures as the global population ages. Extensive research has implicated oxidative stress (OS)-induced retinal damage as a primary contributor to AMD pathogenesis, prompting investigations into potential therapeutic interventions. Among the various nutrients studied for their potential in AMD risk reduction, antioxidants have shown promise, with initial findings from the Age-Related Eye Disease Study suggesting a correlation between antioxidant supplementation and decreased AMD progression. This article explores the scientific foundation supporting the therapeutic efficacy of tocotrienol-rich fraction (TRF) as a viable candidate for slowing AMD progression, based on interventional studies. AMD is characterized by OS, inflammation, dysregulated lipid metabolism, and angiogenesis, all of which TRF purportedly addresses through its potent anti-inflammatory, lipid-lowering, antiangiogenic, and antioxidant properties. The review underscores TRF's promising attributes, aiming to deepen understanding of AMD pathogenesis and advocate for TRF-based pharmacological interventions to enhance therapeutic outcomes. Given the pressing need for effective AMD treatments, TRF represents a promising avenue for intervention, offering hope for improved vision outcomes and enhanced quality of life for individuals affected by this debilitating condition.